US4053626A
(en)
*
|
1973-03-13 |
1977-10-11 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Cholesterol level-lowering phenoxyacetic acids
|
PT656786E
(pt)
*
|
1992-05-19 |
2004-11-30 |
Novogen Res Pty Ltd |
Utilizacao de extractos do fitoestrogenio isoflavona de soja ou trevo
|
US5446061A
(en)
*
|
1993-11-05 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
US5407955A
(en)
*
|
1994-02-18 |
1995-04-18 |
Eli Lilly And Company |
Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
|
US5446071A
(en)
*
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
BR9606890A
(pt)
*
|
1995-01-13 |
1997-10-28 |
Novo Nordisk As |
Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes
|
AUPO203996A0
(en)
*
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
IL129617A0
(en)
*
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5994390A
(en)
*
|
1996-10-28 |
1999-11-30 |
Novo Nordisk |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5985306A
(en)
*
|
1996-10-28 |
1999-11-16 |
Novo Nordisk A/S |
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
|
US5919817A
(en)
*
|
1996-10-28 |
1999-07-06 |
Novo Nordisk A/S |
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
JP2001502706A
(ja)
*
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連病あるいは症候群の予防または治療に有用な新規トランス―3,4クロマン誘導体
|
CA2270113A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Poul Jacobsen |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
JP2001502711A
(ja)
*
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連疾患又は症候群の予防又は治療において有用な新規のシス―3、4―クロマン誘導体
|
US6316494B1
(en)
|
1996-10-28 |
2001-11-13 |
Novo Nordisk A/S |
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US6043269A
(en)
*
|
1996-10-28 |
2000-03-28 |
Novo Nordisk A/S |
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
JP2001502710A
(ja)
*
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連疾患または症候群の予防または治療に有用な新規なシス―3,4―クロマン誘導体
|
ES2188908T3
(es)
*
|
1996-10-28 |
2003-07-01 |
Novo Nordisk As |
Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
|
US5958967A
(en)
*
|
1996-10-28 |
1999-09-28 |
Novo Nordisk A/S |
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
ZA979644B
(en)
*
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
WO1998018772A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
|
ZA979645B
(en)
*
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
US6146668A
(en)
|
1997-04-28 |
2000-11-14 |
Novogen, Inc. |
Preparation of isoflavones from legumes
|
CA2287965C
(en)
*
|
1997-05-01 |
2009-10-20 |
Graham Edmund Kelly |
Treatment or prevention of menopausal symptoms and osteoporosis
|
AUPP112497A0
(en)
*
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
AUPP260798A0
(en)
|
1998-03-26 |
1998-04-23 |
Novogen Research Pty Ltd |
Treatment of medical related conditions with isoflavone containing extracts of clover
|
KR20000001793A
(ko)
*
|
1998-06-13 |
2000-01-15 |
이경하 |
신규한 벤조피란 또는 티오벤조피란 유도체
|
AUPP868599A0
(en)
*
|
1999-02-15 |
1999-03-11 |
Novogen Research Pty Ltd |
Production of isoflavone derivatives
|
AUPQ266199A0
(en)
*
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
US20090233999A1
(en)
*
|
1999-09-06 |
2009-09-17 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
AUPQ520300A0
(en)
*
|
2000-01-21 |
2000-02-17 |
Novogen Research Pty Ltd |
Food product and process
|
JP4896335B2
(ja)
|
2000-03-01 |
2012-03-14 |
ナームローゼ・フエンノートチヤツプ・オルガノン |
エストロゲン化合物としてのクロマン誘導体
|
AUPR363301A0
(en)
*
|
2001-03-08 |
2001-04-05 |
Novogen Research Pty Ltd |
Dimeric isoflavones
|
US20050119301A1
(en)
*
|
2001-03-16 |
2005-06-02 |
Alan Husband |
Treatment of restenosis
|
AU2004290613B2
(en)
*
|
2003-11-18 |
2010-03-25 |
Novogen Research Pty Ltd |
Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
|
US20070244075A1
(en)
*
|
2003-11-18 |
2007-10-18 |
Novogen Research Pty Ltd |
Isoflavonoid Prodrugs, Compositons Thereof and Therapeutic Methods Involving Same
|
US7601855B2
(en)
|
2004-09-21 |
2009-10-13 |
Novogen Research Pty Ltd |
Substituted chroman derivatives, medicaments and use in therapy
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
WO2012061413A2
(en)
|
2010-11-01 |
2012-05-10 |
Marshall Edwards, Inc. |
Isoflavonoid compositions and methods for the treatment of cancer
|
ES2877712T3
(es)
|
2015-02-02 |
2021-11-17 |
Mei Pharma Inc |
Terapias combinadas para su uso en el tratamiento del cáncer de mama
|